FORM 8-K

Company

Estrella Immunopharma, Inc.

Filed

April 5, 2023

Period of Report

April 3, 2023

Accession Number

0001575872-23-000519

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →